Neo, with all due respect, biotron has to walk before it can run. You need to do phase 1 and 2 before you do phase 3 clinical trials. The more successful trials you run as you progress through the cycle, the greater the probability that you will end up with a viable drug. It's as simple as that.
For you to say that the company isn't doing the right sorts of trials is a nonsense. They are doing what is needed, step by step.
If you are saying that they don't have enough cash to support phase 3 trials, then I agree with you but that was never the plan. The company has always said that it expected that level of trialling to be conducted with an agreement from a large pharmaceutical company.
in the zone, page-12
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
-0.001(3.57%) |
Mkt cap ! $24.36M | |||
| Open | High | Low | Value | Volume |
| 2.7¢ | 2.7¢ | 2.7¢ | $1.136K | 42.07K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1950508 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.7¢ | 199924 | 1 |
View Market Depth
| Last trade - 14.29pm 30/08/2024 (20 minute delay) ? |
| BIT (ASX) Chart |